2,2',3,4',5,5',6-heptachlorobiphenyl
structure in first source
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
Related Diseases
1. | Hearing Loss (Hearing Impairment)
05/01/2014
- " The adjusted odds ratio of hearing impairment was significantly increased comparing the highest quartile (Q4) of detectable PCB range with the reference (below LOD): 5.83 (95% CI: 1.20-28.24) for 2,2',3,3',4,4',5-heptachlorobiphenyl (PCB-170), 7.79(95% CI: 1.81-33.44) for 2,2',3,4,4',5,5'-heptachlorobiphenyl (PCB-180), 7.46 (95% CI: 1.62-34.47) for 2,2',3,4',5,5',6-heptachlorobiphenyl (PCB-187), 8.59 (95% CI: 1.26-58.73) for 2,2',3,3',4,4',5,5'-octachlorobiphenyl (PCB-194), 11.62 (95% CI: 2.20-61.55) for 2,2',3,3',4,4',5,6'-octachlorobiphenyl (PCB-196). "
|
|
Related Drugs and Biologics